Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $17.1 million.

  • Merit Medical Systems' Non-Current Deffered Revenue fell 1110.94% to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 1110.94%. This contributed to the annual value of $19.2 million for FY2024, which is 1161.05% up from last year.
  • Per Merit Medical Systems' latest filing, its Non-Current Deffered Revenue stood at $17.1 million for Q3 2025, which was down 1110.94% from $19.8 million recorded in Q2 2025.
  • Merit Medical Systems' Non-Current Deffered Revenue's 5-year high stood at $19.8 million during Q2 2025, with a 5-year trough of $14.8 million in Q3 2022.
  • In the last 5 years, Merit Medical Systems' Non-Current Deffered Revenue had a median value of $17.1 million in 2025 and averaged $17.2 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first plummeted by 1552.1% in 2022, then skyrocketed by 2392.31% in 2024.
  • Quarter analysis of 5 years shows Merit Medical Systems' Non-Current Deffered Revenue stood at $18.1 million in 2021, then decreased by 15.52% to $15.3 million in 2022, then increased by 12.42% to $17.2 million in 2023, then increased by 11.61% to $19.2 million in 2024, then decreased by 11.01% to $17.1 million in 2025.
  • Its last three reported values are $17.1 million in Q3 2025, $19.8 million for Q2 2025, and $18.6 million during Q1 2025.